Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
US6645995B2 · kind B2 · utility
52Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2002 |
| Grant date | Nov 11, 2003 |
| Priority date | — |
| Expiry date | Feb 8, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are compounds of formula I wherein at least one of the bonds in the five-membered ring is a double bond; B is any alpha or beta amino acid connected to the ring with an amide or peptide bond; or a salt thereof with a pharmaceutically acceptable acid or base. Pharmaceutical compositions containing these compounds are also described. These compounds are useful for treating type II diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.